Beijing, China

Wendi Yang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wendi Yang - Innovator in Medical Biotechnology

Introduction

Wendi Yang, an accomplished inventor based in Beijing, China, has made significant contributions to the field of medical biotechnology. With a focus on innovative solutions for health-related issues, her work demonstrates a deep commitment to advancing medical science and technology.

Latest Patents

Yang holds a patent for an "Anti-IL-17 antibody/TNFR ECD fusion protein and use thereof". This invention is pivotal in the realm of medical biotechnology as it relates to a fusion protein that combines an anti-interleukin-17 antibody with a tumor necrosis factor receptor extracellular domain. The patent details various applications, including the treatment, prevention, and diagnosis of diseases related to interleukin-17, showcasing the potential for targeted therapeutic strategies.

Career Highlights

Throughout her career, Wendi Yang has held positions at leading biotechnology firms, including Beijing Beyond Biotechnology Co., Ltd and Hangzhou Polymed Biopharmaceuticals, Inc. Her expertise in protein engineering and therapeutic development has positioned her as a knowledgeable figure within her industry.

Collaborations

Yang has collaborated with notable professionals, including coworkers Pinliang Hu and Jing Zou. These partnerships highlight her ability to work within interdisciplinary teams, fostering innovation through collective expertise and shared goals.

Conclusion

Wendi Yang's contributions to medical biotechnology, underscored by her innovative patent and collaborative spirit, reflect her dedication to improving health outcomes. As the field continues to evolve, her work serves as a foundation for future advancements in medical treatments and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…